Volume 8, Issue 4, July 2022

Safety of AF ablation–its evolution over time and lessons from down under

• Extract
• View article

Sodium-glucose cotransporter 2 inhibitors: the first universal treatment for heart failure?

• Extract
• View article

Do we need to reconsider how we design and conduct randomized controlled trials?

• Extract
• View article

European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary

• Abstracts
• View article

Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

• Abstracts
• View article
• Supplementary data

What is next for screening for undiagnosed atrial fibrillation? Artificial intelligence may hold the key

• Abstract
• View article

Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation

• Abstracts
• View article
• Supplementary data

Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis

• Abstract
• View article
• Supplementary data

Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome

• Abstract
• View article
• Supplementary data

Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries

• Abstract
• View article

Thirteen-year trends in cardiovascular risk in men and women with chronic coronary syndrome

• Abstracts
• View article
• Supplementary data

Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study

• Abstracts
• View article
• Supplementary data

Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism

• Abstract
• View article
• Supplementary data

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

• Abstract
• View article
• Supplementary data

Correspondence to the European Heart Journal—Quality of Care and Clinical Outcomes in response to the paper by Thygesen et al. (2021)

• Extract
• View article

Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

• Extract
• View article